High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients
The Journal of Heart and Lung Transplantation, 06/08/2012
Singer JP et al. – These results suggest that caution should be taken when using voriconazole in LTR because this drug increases the already high risk for SCC in this population.



